Document:

amrn-ex101_224.htm

EXHIBIT 10.1

AMARIN PHARMA INC .

Amarin Pharma Inc.

1430 Route 206, Suite 200

Bedminster, NJ 07921

Tel: 908-719-1315 Fax: 908-719-3012

 

April 20, 2018

 

Mr. Aaron D. Berg 13 Country Place

Lebanon, NJ 08833 Dear Aaron:

This letter agreement (this "Agreement") follows up on our recent discussions regarding your continued employment with Amarin Corporation plc (the "Company"). As you know, the Company desires to continue your employment pursuant to the terms set forth below. Except with respect to the Restrictive Covenants Agreement and the Equity Documents, and subject to Section 15 below, this Agreement supersedes in all respects all prior agreements between you and the Company regarding the subject matter herein, including without limitation any offer letter, employment agreement, or severance agreement. With those understandings, you and the Company agree as follows:

 

1.Position: You shall continue to serve as Senior Vice President. In addition, you shall serve as the Company's Chief Commercial Officer. In such capacity, you will be responsible for Sales, Marketing, and Managed Care. You shall devote your full working time and efforts to the business and affairs of the Company. It is understood and agreed that, while you render services to the Company, you will not engage in any other employment, consulting or other business activities (whether full-time or part-time). Notwithstanding the foregoing, you  may engage in religious, charitable, or other community activities so long as such services or activities do not interfere or conflict with your obligations to the Company. In addition to your role as Senior Vice President and Chief Commercial Officer of the Company, you acknowledge and agree that you may be required, without additional compensation, to perform duties for certain affiliated entities of the Company, including without limitation Amarin Pharma, Inc., and to accept any reasonable office or position with any such affiliate as the Company's Board of Directors may require, including, but not limited to, service as an officer or director of any such affiliate.

 

2.Work Location: Your principal place of employment will continue to be the Company's offices, which are currently located in Bedminster, New Jersey, subject to business travel requirements.

 

3.Salary: The Company will pay you a salary at the annual rate of $424,400, subject to periodic review and adjustment at the discretion of the Company. Currently our policy is to make salary payments semi-monthly.

 

1

 

EXHIBIT 10.1

4.Annual Bonus: Under the Company' s management incentive compensation program, you will be eligible to earn annual performance bonuses. The Company will target the

bonus of up to 40% of your annual salary rate. The actual bonus is discretionary and will be subject to the Company's assessment of your performance, as well as business conditions at the Company. The bonus also will be subject to your employment for the full period covered by the bonus, approval by and adjustment at the discretion of the Company's Board of Directors or an authorized committee thereof, and the terms of any applicable bonus plan. The Company may

also make adjustments in the targeted amount of your annual performance bonus. Any bonus awarded to you will be paid by March 15 of the year following the bonus year to which such bonus relates.

 

5.Benefits: You will continue to be eligible to participate in the employee benefits and insurance programs generally made available to the Company's full-time employees, including health, life, disability and dental insurance. You will be eligible for up to 18 days of paid time off ("PTO") or such other amount determined by the Company, which shall accrue and in other respects be administered in accordance with the Company's policy from time to time. You will be reimbursed for all reasonable business expenses you incur while carrying out your duties on behalf of the Company; provided such reimbursement shall be conditioned on you following the Company's reimbursement policies and claims procedure, including by providing reasonable documentation of such expenses.

 

6.Equity: You shall continue to vest in your outstanding stock options, restricted stock or other equity incentive awards, subject to the terms of the Company's 2011 Stock Incentive Plan (the "Plan"), as may be amended from time to time, and any associated stock option, restricted stock, and/or other equity incentive agreements (collectively, the "Equity Documents"). Notwithstanding anything to the contrary in the Equity Documents, Section 7 of this Agreement shall control with respect to any of your equity interests that are unvested as of the Date of Termination, provided further, nothing herein shall be construed to be less favorable to you than the terms of the Equity Documents.

 

7.At-will Employment, Accrued Obligations; Severance: Your employment shall continue to be “at will,” meaning you or the Company may terminate it at any time for any or no reason. In the event of the termination of your employment for any reason, the Company shall pay you the Accrued Obligations, defined as (1) your base salary through the date of termination, (2) an amount equal to the value of your accrued unused paid time off days, if any, and (3) the amount of any business expenses properly incurred by you on behalf of the Company prior to any such termination and not yet reimbursed, if any, within ten (10) days of the last day of your employment ("Date of Termination"). In addition to the Accrued Obligations, in the event the Company terminates your employment without Cause at any time, or during the twenty-four (24) month period that immediately follows a Change of Control (the "Post-Change in Control Period") the Company terminates your employment without Cause or you terminate your employment for Good Reason (defined below), the Company shall provide you with the following termination benefits (the "Termination Benefits"), depending on the Date of Termination:

 

	
 
	
(i)
	
continuation of your base salary then in effect during the "Salary Continuation Period" which shall be either: (A) six (6) months from the Date of Termination, if the Company terminates your employment without Cause and the Date of
	
 

2

 

EXHIBIT 10.1

Termination occurs at any time outside of the Post-Change in Control Period, or

(B) twelve (12) months from the Date of Termination, if the Company terminates your employment without Cause or you terminate your employment for Good Reason and, in either case, the Date of Termination occurs during the Post-Change in Control Period. Solely for purposes of Section 409A of the Internal Revenue Code of 1986, as amended, each "Salary Continuation Payment" during the Salary Continuation Period is considered a separate payment;

 

	
 
	
(ii)
	
continuation of group health plan benefits to the extent authorized by and consistent with 29 U.S.C. § 1161 et seq. (commonly known as "COBRA"), with the cost of the regular premium for such benefits shared in the same relative proportion by the Company and you as in effect on the Date of Termination until the earlier of: (i) the end of the Salary Continuation Period, and (ii) the date you become eligible for health benefits through another employer or otherwise become ineligible for COBRA;
	
 

 

	
 
	
(iii)
	
if the Company terminates your employment without Cause or you terminate your employment for Good Reason and, in either case, the Date of Termination occurs during the Post-Change in Control Period, a lump sum cash payment equal to your target annual performance bonus for the year during which the Date of Termination occurs;
	
 

 

	
 
	
(iv)
	
if the Company terminates your employment without Cause and the Date of Termination occurs outside of the Post-Change in Control Period, six (6) months of accelerated vesting from the Date of Termination with respect to any of your then outstanding stock options, restricted stock units or other equity incentive awards (in each case, only to the extent subject to time-based vesting); and
	
 

 

	
 
	
(v)
	
if the Company terminates your employment without Cause or you terminate your employment for Good Reason and, in either case, the Date of Termination occurs during the Post-Change in Control Period, then outstanding stock options, restricted stock units or other equity incentive awards (whether or not subject to time based vesting) shall immediately vest in full effective upon the Date of Termination.
	
 

 

Notwithstanding anything to the contrary in this Agreement, you shall not be entitled to any Termination Benefits unless you first (i) enter into, do not revoke, and comply with the terms of a separation agreement in a form acceptable to the Company which shall include a release of claims against the Company and related persons and entities (the "Release"), provided that the Release shall not require you to release (a) claims to enforce your right to receive Termination Benefits; (b) claims for vested benefits pursuant to ERJSA; (c) claims with respect to your vested equity rights as of the Date of Termination; (d) claims to enforce the Company's obligation to indemnify you to the extent such indemnification obligations exist; and (e) claims which legally may not be waived; (ii) resign from any and all positions, including, without implication of

 

 

 

3

 

EXHIBIT 10.1

limitation, as  a  director, trustee, and officer, that  you  then  hold with the  Company and any affiliate of the Company; and (iii) return all Company property and comply with any instructions related to deleting and purging duplicates of such Company property, in each case within the time period designated by the Company but in no event later than 60 days of the Date of Termination. The Salary Continuation Payments shall commence within 60 days after the Date of Termination and shall be made on the Company's regular payroll dates; provided, however, that if the 60-day period begins in one calendar year and ends in a second calendar year, the Salary Continuation Payments shall begin to be paid in the second calendar year. In the event you miss a regular payroll period between the Date of Termination and first Salary Continuation Payment, the first Salary Continuation Payment shall include a "catch up" payment.

 

Notwithstanding the foregoing, if you breach any of the material provisions of this Agreement or the Restrictive Covenants Agreement, in addition to all other rights and remedies, the Company shall have the right to terminate or cease payment of the Termination Benefits. For the avoidance of doubt, you shall not be entitled to the Termination Benefits in the event your employment ends due to your death or disability.

 

8.Definitions: For purposes of this Agreement, the following terms shall have the following meanings:

 

"Cause" shall mean: (i) conduct by you constituting an act of material misconduct in connection with the performance of your duties, including, without limitation, misappropriation of funds or property of the Company other than the occasional, customary and de minimis use of Company property for personal purposes; (ii) the commission by you of (A) any felony; or (B) a misdemeanor involving moral turpitude, deceit, dishonesty or fraud; (iii) any conduct by you that would reasonably be expected to result in material injury or reputational harm to the Company or any of its subsidiaries and affiliates if you were retained; (iv) continued non-performance or continued unsatisfactory performance by you of your responsibilities as reasonably determined by the Company's Board of Directors; (v) a breach by you of any of the material provisions of any agreement between you and the Company including, without limitation, any agreement relating to non-disclosure, non-competition or assignment of inventions; (vi) a material violation by you of any of the Company's written policies or procedures provided that, other than in the case of noncurable events, you are provided with written notice and fifteen (15) days to cure.

 

The meaning of "Change of Control" shall be limited to the following events, but only to the extent such events constitute a "change in the ownership or effective control" of the Company or a "change in the ownership of a substantial portion of the Company's assets" for purposes of Section 409A of the Code:

 

	
 
	
(i)
	
any person or company (either alone or together with any person or company acting in concert with him or it) (an "Acquiring Company") obtaining Control of the Company,
	
 

 

	
 
	
(ii)
	
any person or company that Controls the Company becoming bound or entitled to acquire Shares under sections 974 to 991 of the UK Companies Act 2006,
	
 

	
 
	
(iii)
	
any court sanctioning a compromise or arrangement under section 899 of the UK Companies Act 2006,
	
 

 

4

 

EXHIBIT 10.1

	
 
	
(iv)
	
a resolution being tabled for the voluntary winding-up of the Company,

 

	
 
	
(v)
	
any Acquiring Company acquiring all or substantially all of the assets of the Company,
	
 

 

	
 
	
(vi)
	
any merger, reorganization, consolidation or other similar transaction pursuant to which the holders of the Company's outstanding voting power and outstanding stock immediately prior to such transaction do not own a majority of the outstanding voting power and outstanding stock or other equity interests of the Company or any resulting or successor entity (or its ultimate parent, if applicable) immediately upon completion of such transaction,
	
 

 

	
 
	
(vii)
	
the sale of all or a majority of the Shares of the Company to an unrelated person, entity or group thereof acting in concert, or
	
 

 

	
 
	
(viii)
	
any other similar transaction which the Board determines should constitute a Change of Control for the purposes of the Plan.
	
 

 

"Control" shall mean the ownership of more than fifty (50) percent of the issued share capital or other equity interest of the Company or the legal power to direct or cause the direction of the general management and policies of the Company.

 

"Good Reason" shall mean that you have complied with "Good Reason Process" (hereinafter defined) following the occurrence of any of the following Good Reason conditions that occur without your consent: (i) a material diminution of your base salary; (ii) a material diminution in your authority, duties or responsibilities; (iii) a material change in the principal location where you are required to provide services for the Company (not including business travel and short­ term assignments); and/or (iv) a material breach by the Company of this Agreement. For purposes of this Agreement, "Good Reason Process" shall mean that: (x) you reasonably determine in good faith that a "Good Reason" condition has occurred; (y) you notify the Company in writing of the Good Reason condition within thirty (30) days of the first occurrence of such condition; (z) you cooperate in good faith with the Company's efforts, for a period of thirty (30) days following such notice (the "Cure Period"), to remedy the condition; notwithstanding such efforts, the Good Reason condition continues to exist; and you terminate your employment within thirty (30) days after the end of the Cure Period. If the Company cures the Good Reason condition during the Cure Period, Good Reason shall be deemed not to have occurred.

 

9.Section 280G Limitation: Anything in this Agreement to the contrary notwithstanding, in the event that the amount of any compensation, payment or distribution by the Company to or for the benefit of you, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise, calculated in a manner consistent with Section 2800 of the Code and the applicable regulations thereunder (the "Severance Payments"), would be subject to the excise tax imposed by Section 4999 of the Code, the following provisions shall apply:

 

 

 

 

 

5

 

EXHIBIT 10.1

(a)If the Severance Payments, reduced by the sum of (1) the Excise Tax and (2) the total of the Federal, state, and local income and employment taxes payable by you on the amount of the Severance Payments which are in excess of the Threshold Amount, are greater than or equal to the Threshold Amount, you shall be entitled to the full benefits payable under this Agreement.

 

	
 
	
(b)
	
If the Threshold Amount is less than (x) the Severance Payments, but greater than

(y)the Severance Payments reduced by the sum of (1) the Excise Tax and (2) the total of the Federal, state, and local income and employment taxes on the amount of the Severance Payments which are in excess of the Threshold Amount, then the Severance Payments shall be reduced (but not below zero) to the extent necessary so that the sum of all Severance Payments shall not exceed the Threshold Amount. In such event, the Severance Payments shall be reduced in the following order: (1) cash payments not subject to Section 409A of the Code; (2) cash payments subject to Section 409A of the Code; (3) equity-based payments and acceleration; and (4) non­ cash forms of benefits. To the extent any payment is to be made over time (e.g., in installments, etc.), then the payments shall be reduced in reverse chronological order.

 

(c)For the purposes of this Section, "Threshold Amount" shall mean three times your "base amount" within the meaning of Section 280G(b)(3) of the Code and the regulations promulgated thereunder less one dollar ($1.00); and "Excise Tax" shall mean the excise tax imposed by Section 4999 of the Code, and any interest or penalties incurred by you with respect to such excise tax.

 

(d)The determination as to which of the alternative provisions of this Section 10 shall apply to you shall be made by a nationally recognized accounting firm selected by the Company (the "Accounting Firm"), which shall provide detailed supporting calculations both to the Company and you within 15 business days of the Date of Termination, if applicable, or at such earlier time as is reasonably requested by the Company or you. For purposes of determining which of the alternative provisions of this Section 10 shall apply, you shall be deemed to pay federal income taxes at the highest marginal rate of federal income taxation applicable to individuals for the calendar year in which the determination is to be made, and state and local income taxes at the highest marginal rates of individual taxation in the state and locality of your residence on the date of termination, net of the maximum reduction in federal income taxes which could be obtained from deduction of such state and local taxes. Any determination by the Accounting Firm shall be binding upon the Company and you.

 

10.Taxes; Section 409A: All forms of compensation referred to in this Agreement are subject to reduction to reflect applicable withholdings and payroll taxes and other deductions required by law. You hereby acknowledge that the Company does not have a duty to design its compensation policies in a manner that minimizes tax liabilities. Anything in this Agreement to the contrary notwithstanding, if at the time of your separation from service within the meaning of Section 409A of the Code, the Company determines that you are a "specified employee" within the meaning of Section 409A(a)(2)(B)(i) of the Code, then to the extent any payment or benefit that you become entitled to under this Agreement on account of your separation from service would be considered deferred compensation subject to the 20 percent additional tax imposed pursuant to Section 409A(a) of the Code as a result of the application of Section

 

 

 

6

 

EXHIBIT 10.1

409A(a)(2)(B)(i) of the Code, such payment shall not be payable and such benefit shall not be provided until the date that is the earlier of (A) six months and one day after your separation from service, or (B) your death. If any such delayed cash payment is otherwise payable on an installment basis, the first payment shall include a catch-up payment covering amounts that would otherwise have been paid during the six-month period but for the application of this provision, and the balance of the installments shall be payable in accordance with their original schedule.

 

All in-kind benefits provided and expenses eligible for reimbursement under this Agreement shall be provided by the Company or incurred by you during the time periods set forth in this Agreement. All reimbursements shall be paid as soon as administratively practicable, but in no event shall any reimbursement be paid after the last day of the taxable year following the taxable year in which the expense was incurred. The amount of in-kind benefits provided or reimbursable expenses incurred in one taxable year shall not affect the in-kind benefits to be provided or the expenses eligible for reimbursement in any other taxable year. Such right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit.

 

To the extent that any payment or benefit described in this Agreement constitutes "non-qualified deferred compensation" under Section 409A of the Code, and to the extent that such payment or benefit is payable upon the termination of this Agreement, then such payments or benefits shall be payable only upon your "separation from service." The determination of whether and when a separation from service has occurred shall be made in accordance with the presumptions set forth in Treasury Regulation Section l.409A-l(h).

 

The parties intend that this Agreement will be administered in accordance with Section 409A of the Code. To the extent that any provision of this Agreement is ambiguous as to its compliance with Section 409A of the Code, the provision shall be read in such a manner so that all payments hereunder comply with Section 409A of the Code. The parties agree that this Agreement may be amended, as reasonably requested by either party, and as may be necessary to fully comply with Section 409A of the Code and all related rules and regulations in order to preserve the payments and benefits provided hereunder without additional cost to either party.

 

The Company makes no representation or warranty and shall have no liability to you or any other person if any provisions of this Agreement are determined to constitute deferred compensation subject to Section 409A of the Code but do not satisfy an exemption from, or the conditions of, such Section.

 

11.Restrictive Covenants Agreement: You acknowledge your continuing obligations under your Nondisclosure, Developments and Noncompetition Agreement dated November 19, 2012, which, among other things, prohibits disclosure of any confidential or proprietary information of the Company (the "Restrictive Covenants Agreement"). A copy of the Restrictive Covenants Agreement is attached as Exhibit A, and the terms are incorporated by reference as material terms of this Agreement.

 

12.Representation Regarding Other Obligations: You reaffirm that you are not subject to any confidentiality, non-competition agreement or any other similar type of restriction that may affect your ability to devote full time and attention to your work at the Company. If you have entered into any agreement that may restrict your activities on behalf of the 

7

 

EXHIBIT 10.1

Company, please provide me with a copy of the agreement as soon as possible.

 

13.Protected Disclosures: Nothing in this Agreement or the Restrictive Covenants Agreement shall be interpreted or applied to prohibit you from making any good faith report to any governmental agency or other governmental entity (a "Government Agency") concerning any act or omission that you reasonably believe constitutes a possible violation of federal or state law or making other disclosures that are protected under the anti-retaliation or whistleblower provisions of applicable federal or state law or regulation. In addition, nothing contained in this Agreement limits your ability to communicate with any Government Agency or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including your ability to provide documents or other information, without notice to the Company.

 

14.Other Terms: Your employment with the Company shall continue to be on an at- will basis. In other words, you or the Company may terminate employment for any reason and at any time, with or without notice, subject to the Termination Benefits provisions herein. Similarly, the terms of employment outlined in this Agreement are subject to change at any time. In addition, this Agreement is contingent on the completion of references checks and a background investigation that are satisfactory to the Company (as determined by the Company) and your submission of satisfactory proof of your identity and your legal authorization to work in the United States and a satisfactory Company paid initial-employment physical and drug screen, in each case to the extent not already completed.

15.Interpretation, Amendment and Enforcement: This Agreement, including the Restrictive Covenants Agreement and the Equity Documents, constitute the complete agreement between you and the Company, contain all of the terms of your employment with the Company and supersede any prior agreements, representations or understandings (whether written, oral or implied) between you and the Company with regard to this subject matter, provided that the Deed of Indemnity between the Company and you dated April 21, 2015 (the "Deed of Indemnity"), the Letter Agreement dated April _ , 2018, and the "Release of Claims" (as defined and preserved in the Letter Agreement) shall remain in full force and effect in accordance with their terms. This Agreement may not be modified or amended except in a writing signed by both you and a duly authorized officer of the Company. The terms of this Agreement and the resolution of any disputes as to the meaning, effect, performance or validity of this Agreement or arising out of, related to, or in any way connected with, this Agreement, your employment with

)

 
the Company or any other relationship between you and the Company (the “Disputes”)  will be
governed by the laws of the State of New Jersey, excluding laws relating to conflicts or choice of law. You and the Company submit to the exclusive personal jurisdiction of the federal and state courts located in the State of New Jersey in connection with any Dispute or any claim related to any Dispute.

 

16.Assignment: Neither you nor the Company may make any assignment of this Agreement or any interest in it, by operation of law or otherwise, without the prior written consent of the other; provided, however, that the Company may assign its rights and obligations under this Agreement without your consent to one of its Affiliates or to any person with whom the Company shall hereafter effect a reorganization, consolidate with, or merge into or to whom

 

 

8

 

EXHIBIT 10.1

it transfers all or substantially all of its properties or assets. This Agreement shall inure to the benefit of and be binding upon you and the Company, and each of our respective successors, executors, administrators, heirs and permitted assigns.

 

We look forward to continuing to work with you at Amarin. If you have any questions about this information, please do not hesitate to call. Otherwise, please confirm your acceptance of this Agreement by signing below and returning a copy to me. This Agreement shall become effective on the date when it becomes fully executed (the "Effective Date"). PDF and facsimile signatures shall have the same legal effect as originals.

 

Signed for and on behalf of:

 

AMARIN CORPORATION PLC

 

		
	
Signed:
	
/s/ John F. Thero

	
Dated:
	
April 20, 2018

 

      

        ACCEPTED:

 

		
	
Signed:
	
/s/ Aaron D. Berg

	
Name:
	
Aaron D. Berg

	
Dated:
	
May 17, 2018

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9

 

Exhibit A

Nondisclosure , Developments and Noncompetition AgreementExhibit

Exhibit 10.1

AMENDMENT NO. 4 TO CREDIT AGREEMENT
Amendment No. 4, dated as of March 7, 2019 (this “Amendment”), by and among XPO LOGISTICS, INC., a Delaware corporation (the “Borrower”), certain of the Borrower’s Subsidiaries signatory hereto, the Lenders party hereto and MORGAN STANLEY SENIOR FUNDING, INC., in its capacity as administrative agent and collateral agent for the Lenders (in such capacities, the “Agent”), relating to the Senior Secured Term Loan Credit Agreement, dated as of October 30, 2015 (as heretofore amended, amended and restated, extended, supplemented or otherwise modified from time to time prior to the date hereof, including by that certain Incremental and Refinancing Amendment (Amendment No. 1 to Credit Agreement), dated as of August 25, 2016, that certain Refinancing Amendment (Amendment No. 2 to Credit Agreement), dated as of March 10, 2017 and that certain Refinancing Amendment (Amendment No. 3 to Credit Agreement), dated as of February 23, 2018, the “Credit Agreement”), among the Borrower, the Subsidiaries of the Borrower from time to time party thereto, the Lenders from time to time party thereto and the Agent.
WHEREAS, the Borrower and the Requisite Lenders have agreed to amend the Credit Agreement as set forth herein.
NOW, THEREFORE, in consideration of the premises contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound hereby, agree as follows:
Section 1.    Defined Terms.  Unless otherwise specifically defined herein, each term used herein that is defined in the Credit Agreement has the meaning assigned to such term in the Credit Agreement.
Section 2.    Amendment.  Effective as of the Amendment No. 4 Closing Date (as defined below), clause (v) of the proviso to Section 2.15(c) shall be amended to read in its entirety as follows: 
“(v) with respect to any Incremental Loans incurred pursuant to clause (a) of this Section 2.15, if the All-in Yield on such Incremental Loans exceeds the initial All-in Yield for any existing Loans by more than 50 basis points (or, in the case of up to $500,000,000 aggregate principal amount of such Incremental Loans incurred on or prior to the date that is 90 days after March 7, 2019, 75 basis points) (the amount of such excess above 50 or 75 basis points, as applicable, being referred to herein as the “Yield Differential”), then the Applicable Margin for such existing Loans shall automatically be increased by the Yield Differential applicable to such Loans, effective upon the making of the Incremental Loans (and Borrower shall be entitled, without the consent of any other Lender, to increase the All-in Yield on any Loans as necessary to ensure the Incremental Loans are “fungible” with any existing Loans),”.
Section 3.    Representations and Warranties.  The Borrower and each other Credit Party hereby represents and warrants to the Agent and the Lenders that on the Amendment No. 4 Closing Date:
(i)    no Default or Event of Default shall have occurred and be continuing immediately prior to or immediately after the effectiveness of this Amendment; and
(ii)    the representations and warranties set forth in Section 4 of the Credit Agreement and in each other Loan Document shall be true and correct in all material respects on and as of the Amendment No. 4 Closing Date, except to the extent that such representations or warranties expressly 

 

relate to an earlier date, in which case they shall be true and correct in all material respects as of such earlier date; 
Section 4.    Effectiveness.  This Amendment shall become effective as of the first date when each of the following conditions shall have been satisfied (the date of satisfaction of such conditions, which date is March 7, 2019, the “Amendment No. 4 Closing Date”):
(i)    The Agent shall have received from the Borrower, each other Credit Party, the Agent and Requisite Lenders (each Lender party hereto, a “Consenting Lender”, and collectively, the “Consenting Lenders”) an executed counterpart hereof or other written confirmation (in form satisfactory to the Agent) that such party has signed a counterpart hereof;
(ii)    The Agent shall have received, for the ratable account of the Consenting Lenders, an amendment fee equal to $1,503,000, which fee shall be shared among the Consenting Lenders based on each Consenting Lender’s pro rata share of the outstanding Loans held by all Consenting Lenders immediately prior to the effectiveness of this Amendment;
(iii)    All fees and out-of-pocket expenses of the Agent required to be paid or reimbursed by the Borrower on the Amendment No. 4 Closing Date under Section 12.3 of the Credit Agreement, shall, to the extent invoiced and provided in writing to the Borrower at least one Business Day prior to the Amendment No. 4 Closing Date, have been paid or reimbursed; and
(iv)    The representations and warranties made pursuant to Section 3 hereof shall be true and correct in all material respects on and as of the Amendment No. 4 Closing Date, except to the extent that such representations or warranties expressly relate to an earlier date, in which case they shall be true and correct in all material respects as of such earlier date; 
Section 5.    Governing Law. This Amendment shall be governed by and construed and interpreted in accordance with the laws of the State of New York.
Section 6.    Credit Agreement Governs. Except as expressly set forth herein, this Amendment shall not by implication or otherwise limit, impair, constitute a waiver of or otherwise affect the rights and remedies of any Lender or the Agent under the Credit Agreement or any other Loan Document, and shall not alter, modify, amend or in any way affect any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or any other Loan Document, all of which are ratified and affirmed in all respects and shall continue in full force and effect.  Nothing herein shall be deemed to entitle any Credit Party to a future consent to, or a waiver, amendment, modification or other change of, any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or any other Loan Document in similar or different circumstances.  This Amendment shall constitute a Loan Document for purposes of the Credit Agreement and from and after the Amendment No. 4 Closing Date, all references to the Credit Agreement in any Loan Document and all references in the Credit Agreement to “this Agreement,” “hereunder,” “hereof” or words of like import referring to the Credit Agreement, shall, unless expressly provided otherwise, refer to the Credit Agreement as amended by this Amendment.  
Section 7.    Counterparts. This Amendment may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. Delivery of an executed counterpart of a signature page to this Amendment by facsimile or electronic (i.e., “pdf” or “tif”) transmission shall be effective as delivery of a manually executed counterpart of this Amendment.
[Remainder of page intentionally left blank]

-2-

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as of the date first above written.
	
					
	BORROWER:
	 

	 
	 
	 
	 
	 

	 
	 
	 
	 
	 

	XPO LOGISTICS, INC.
	 

	 
	 
	 
	 
	 

	 
	 
	 
	 
	 

	 
	 
	 
	 
	 

	By:
	/s/ Ravi Tulsyan
	 

	 
	Name:  Ravi Tulsyan
	 

	 
	Title:    Senior Vice President and Treasurer
	 

 [Signature Page – Amendment No. 4 to XPO Senior Secured Term Loan Credit Agreement]

	
		
	GUARANTORS:

	BOUNCE LOGISTICS, LLC

	CON-WAY MULTIMODAL INC.

	MANUFACTURERS CONSOLIDATION SERVICE OF

	 
	CANADA, INC.

	XPO AIR CHARTER, LLC

	XPO CNW, INC.

	XPO COURIER, LLC

	XPO CUSTOMS CLEARANCE SOLUTIONS, LLC

	XPO DEDICATED, LLC

	XPO ENTERPRISE SERVICES, INC.

	XPO GLOBAL FORWARDING, INC.

	XPO INTERMODAL, INC.

	XPO INTERMODAL SERVICES, LLC

	XPO INTERMODAL SOLUTIONS, INC.

	XPO LAND HOLDINGS, LLC

	XPO LAST MILE, INC.

	XPO LAST MILE HOLDING, INC.

	XPO LOGISTICS CARTAGE, LLC

	XPO LOGISTICS DRAYAGE, LLC

	XPO LOGISTICS EXPRESS, LLC

	XPO LOGISTICS FREIGHT, INC.

	XPO LOGISTICS MANAGED TRANSPORTATION, LLC

	XPO LOGISTICS MANUFACTURING, LLC

	XPO LOGISTICS NLM, LLC

	XPO LOGISTICS PORT SERVICES, LLC

	XPO LOGISTICS SUPPLY CHAIN CORPORATE SERVICES,

	 
	INC.

	XPO LOGISTICS SUPPLY CHAIN HOLDING COMPANY

	XPO LOGISTICS SUPPLY CHAIN OF NEW JERSEY, LLC

	XPO LOGISTICS SUPPLY CHAIN OF TEXAS, LLC

	XPO LOGISTICS SUPPLY CHAIN, INC.

	XPO LOGISTICS WORLDWIDE GOVERNMENT SERVICES,

	 
	LLC

	XPO LOGISTICS WORLDWIDE, INC.

	XPO LOGISTICS WORLDWIDE, LLC

	XPO LOGISTICS, LLC

	XPO LTL SOLUTIONS, INC.

	XPO PROPERTIES, INC.

	XPO SERVCO, LLC

	XPO STACKTRAIN, LLC

	XPO TRANSPORT, LLC

	
					
	By:
	/s/ Ravi Tulsyan
	 

	 
	Name:  Ravi Tulsyan
	 

	 
	Title:    Senior Vice President and Treasurer
	 

[Signature Page – Amendment No. 4 to XPO Senior Secured Term Loan Credit Agreement]

	
					
	PDS TRUCKING, INC.
	 

	XPO DISTRIBUTION SERVICES, INC.
	 

	 
	 
	 
	 
	 

	 
	 
	 
	 
	 

	By:
	/s/ Dominick Muzi
	 

	 
	Name:  Dominick Muzi
	 

	 
	Title:    President & Chief Operating Officer
	 

	
					
	CTP LEASING, INC.
	 

	 
	 
	 
	 
	 

	 
	 
	 
	 
	 

	 
	 
	 
	 
	 

	By:
	/s/ Donald Powers
	 

	 
	Name:  Donald Powers
	 

	 
	Title:    President
	 

[Signature Page – Amendment No. 4 to XPO Senior Secured Term Loan Credit Agreement]

	
					
	AGENT:
	 

	 
	 
	 
	 
	 

	MORGAN STANLEY SENIOR FUNDING, INC., as Agent
	 

	 

	 
	 
	 
	 
	 

	 
	 
	 
	 
	 

	By:
	/s/ Chance Moreland
	 

	Names:
	Chance Moreland
	 

	Title
	Authorized Signatory
	 

[Signature Page – Amendment No. 4 to XPO Senior Secured Term Loan Credit Agreement]

LENDERS’ SIGNATURE PAGES
[Held on file with Agent]

[Signature Page – Amendment No. 4 to XPO Senior Secured Term Loan Credit Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00295-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00295-of-00352.parquet"}]]